Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
Nature Medicine|December 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaquesPeng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.Cell|September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primatesEric M Mucker, Alec W Freyn, Sandra L Bixler, et al.Annals of the New York Academy of Sciences|November 16, 2022
Antibodies as drugs-a Keystone Symposia reportJennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, et al.Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.Science (New York, N.Y.)|May 16, 2024
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodiesZhenfei Xie, Ying-Cing Lin, Jon M Steichen, et al.Plos One|April 27, 2018
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvantYingxia Wen, Hung V Trinh, Christine E Linton, et al.Science Translational Medicine|December 1, 2022
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year laterEmma C Milligan, Katherine Olstad, Caitlin A Williams, et al.Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.Immunity|April 15, 2026
Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaquesNitesh Mishra, Bo Liang, Ryan S Roark, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaquesNitesh Mishra, Bo Liang, Ryan S Roark, et al.Pageof 12